Among 5 analysts covering MSG Networks (MSGN), 1 have Buy rating, 1 Sell and 3 Hold. Therefore 20% are positive. MSG Networks had 6 analyst reports since March 29, 2016 according to SRatingsIntel. The firm earned “Sector Weight” rating on Tuesday, March 29 by Pacific Crest. On Tuesday, August 9 the stock rating was initiated by Loop Capital with “Hold”. Guggenheim upgraded the stock to “Buy” rating in Friday, December 9 report. The firm earned “Neutral” rating on Wednesday, April 5 by Macquarie Research. The company was maintained on Monday, July 11 by Jefferies. Loop Capital downgraded the shares of MSGN in report on Friday, December 16 to “Sell” rating.
Among 3 analysts covering Cidara Therapeutics (NASDAQ:CDTX), 2 have Buy rating, 1 Sell and 0 Hold. Therefore 67% are positive. Cidara Therapeutics has $25 highest and $13 lowest target. $19’s average target is 155.03% above currents $7.45 stock price. Cidara Therapeutics had 4 analyst reports since October 9, 2015 according to SRatingsIntel. The firm earned “Buy” rating on Monday, December 19 by H.C. Wainwright. The stock has “Outperform” rating by Leerink Swann on Wednesday, December 21. WBB Securities upgraded Cidara Therapeutics Inc (NASDAQ:CDTX) on Friday, October 9 to “Hold” rating. WBB Securities downgraded the shares of CDTX in report on Friday, September 23 to “Sell” rating. See Cidara Therapeutics Inc (NASDAQ:CDTX) latest ratings:
21/12/2016 Broker: Leerink Swann Rating: Outperform Reinitiate
19/12/2016 Broker: H.C. Wainwright Rating: Buy New Target: $25.00 Initiate
MSG Networks Inc., formerly The Madison Square Garden Company, is engaged in sports production, and content development and distribution. The company has market cap of $1.91 billion. The Firm owns and operates two regional sports and entertainment networks, MSG Network and MSG+, collectively MSG Networks. It has a 10.53 P/E ratio. The Company’s networks are distributed throughout its territory, which includes all of New York State and significant portions of New Jersey and Connecticut, as well as parts of Pennsylvania.
Analysts await MSG Networks Inc (NYSE:MSGN) to report earnings on May, 3. They expect $0.61 EPS, up 3.39% or $0.02 from last year’s $0.59 per share. MSGN’s profit will be $48.85 million for 9.77 P/E if the $0.61 EPS becomes a reality. After $0.57 actual EPS reported by MSG Networks Inc for the previous quarter, Wall Street now forecasts 7.02% EPS growth.
The stock decreased 2.45% or $0.6 during the last trading session, reaching $23.85. About shares traded. MSG Networks Inc (MSGN) has risen 35.90% since August 30, 2016 and is uptrending. It has outperformed by 27.77% the S&P500.
The stock increased 6.43% or $0.45 during the last trading session, reaching $7.45. About shares traded. Cidara Therapeutics Inc (NASDAQ:CDTX) has declined 35.16% since August 30, 2016 and is downtrending. It has underperformed by 43.29% the S&P500.
